These two ASX shares couldn’t be more different, yet both make sense to me heading into 2026. The post Why I think CSL and ...

The 1971 BMW 3.0 CSL did not begin life as a collector’s darling or a design statement. It was conceived as a blunt ...

The CSL Ltd ( ASX: CSL) share price has tested investor patience like few other blue chips in recent memory. After falling ...

When Fanatec revealed last year that it was bringing a direct drive wheel base to market for just $350, sim racers sort of lost it. Direct drive is the cream of the crop in terms of force feedback ...

CSL Limited, a biotechnology company that produce many of its biological products from plasma, is diversifying its portfolio and its drug pipeline through its largest ever acquisition: the purchase of ...

In an effort to drum up hype for its newly released M4 CSL, BMW is revealing a bunch of never-before-seen CSL concepts to the public. Earlier this week it showed off a V-8-powered M3 CSL alongside the ...

Steven Ewing spent his childhood reading car magazines, making his career as an automotive journalist an absolute dream job. After getting his foot in the door at Automobile while he was still a ...

CSL Ltd (ASX: CSL) shares were sold off in 2025. Let's find out why and see if this is a buying opportunity for ...

After an antitrust review knocked 2021’s biggest biopharma buyout off course in May, CSL’s $11.7 billion deal for Swiss iron deficiency specialist Vifor Pharma appears to be back on track. Tuesday, ...

With plasma collection as its stock-in-trade, the struggles of CSL during the coronavirus lockdown were understandable. But a rebound—fueled by a surge in post-pandemic collections and an $11.7 ...

CSL Behring’s largest-ever trial has ended in failure, as the Australian pharma revealed that its cholesterol efflux enhancer was unable to reduce the risk of heart attacks. The company had been ...